Log in to save to my catalogue

Comparing progression biomarkers in clinical trials of early Alzheimer’s disease

Comparing progression biomarkers in clinical trials of early Alzheimer’s disease

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_6aac7c2958e143a484d74e78928e9158

Publication information

Publisher

United States: John Wiley & Sons, Inc

More information

Scope and Contents

Contents

Objective
To investigate the statistical power of plasma, imaging, and cognition biomarkers as Alzheimer’s disease (AD) clinical trial outcome measures.
Methods
Plasma neurofilament light, structural magnetic resonance imaging, and cognition were measured longitudinally in the Alzheimer’s Disease Neuroimaging Initiative (ADNI) in control (...

Alternative Titles

Full title

Comparing progression biomarkers in clinical trials of early Alzheimer’s disease

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_6aac7c2958e143a484d74e78928e9158

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_6aac7c2958e143a484d74e78928e9158

Other Identifiers

ISSN

2328-9503

E-ISSN

2328-9503

DOI

10.1002/acn3.51158

How to access this item

Log in as a Library member